University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction

Agouni, A, Tual-Chalot, S, Chalopin, M, Duluc, L, Mody, N, Martinez, MC, Andriantsitohaina, R and Delibegović, M (2014) Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction Biochemical Pharmacology.

Full text not available from this repository.

Abstract

Growing evidence suggests that hepatic-insulin resistance is sufficient to promote progression to cardiovascular disease. We have shown previously that liver-specific protein-tyrosine-phosphatase 1B (PTP1B) deficiency improves hepatic-insulin sensitivity and whole-body glucose homeostasis. The aim of this study was to investigate the impact of liver-specific PTP1B-deficiency (L-PTP1B-/-) on cardiac and peripheral vascular function, with special emphasis on endothelial function in the context of high-fat diet (HFD)-induced obesity. L-PTP1B-/- mice exhibited an improved glucose and lipid homeostasis and increased insulin sensitivity, without changes in body weight. HFD-feeding increased systolic blood pressure (BP) in both L-PTP1B-/- and control littermates; however, this was significantly lower in L-PTP1B-/- mice. HFD-feeding increased diastolic BP in control mice only, whilst the L-PTP1B-/- mice were completely protected. The analysis of the function of the left ventricle (LV) revealed that HFD-feeding decreased LV fractional shortening in control animals, which was not observed in L-PTP1B−/− mice. Importantly, HFD feeding significantly impaired endothelium-dependent vasorelaxation in response to acetylcholine in aortas from control mice, whilst L-PTP1B−/− mice were fully protected. This was associated with alterations in eNOS phosphorylation. Selective inhibition of COX-2, using NS-398, decreased the contractile response in response to serotonin (5-HT) only in vessels from control mice. HFD-fed control mice released enhanced levels of prostaglandin E, a vasoconstrictor metabolite; whilst both chow- and HFD-fed L-PTP1B−/− mice released higher levels of prostacylin, a vasorelaxant metabolite. Our data indicate that hepatic-PTP1B inhibition protects against HFD-induced endothelial dysfunction, underscoring the potential of peripheral PTP1B inhibitors in reduction of obesity-associated cardiovascular risk in addition to its anti-diabetic effects.

Item Type: Article
Authors :
NameEmailORCID
Agouni, Aa.agouni@surrey.ac.ukUNSPECIFIED
Tual-Chalot, SUNSPECIFIEDUNSPECIFIED
Chalopin, MUNSPECIFIEDUNSPECIFIED
Duluc, LUNSPECIFIEDUNSPECIFIED
Mody, NUNSPECIFIEDUNSPECIFIED
Martinez, MCUNSPECIFIEDUNSPECIFIED
Andriantsitohaina, RUNSPECIFIEDUNSPECIFIED
Delibegović, MUNSPECIFIEDUNSPECIFIED
Date : 21 October 2014
Identification Number : 10.1016/j.bcp.2014.10.008
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:21
Last Modified : 17 May 2017 14:49
URI: http://epubs.surrey.ac.uk/id/eprint/827442

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800